Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-19

Clinical Trial Update: Intravenous Nalbuphine Versus Intravenous Dexmedetomidine for Conscious Sedation in Patients Undergoing Colonoscopy [Phase 4]

View source ↗

Summary

Phase 4 trial updating a comparison between intravenous nalbuphine and intravenous dexmedetomidine for conscious sedation in colonoscopy patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Nalbuphine (nalbuphine)

Snippet

Sponsor: Assiut University | Conditions: Colonoscopy | Phase 4 | Status: UNKNOWN